ACCESS

At the 4th ASCERTAIN Consortium meeting during the EHA Congress in Madrid, we presented 1.5 years of progress, discussing key findings on health technology assessments, fair pricing models, and innovative approaches to patient access. Our focus includes developing transparent and adaptable pricing methods, incorporating cost-effectiveness models, and promoting sustainable healthcare solutions... Our Goal: Improving Affordability and Sustainability of Innovative Health Technologies through the ASCERTAIN Project... ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe.

Registration numbers: HRB 87604 am 20.06.2003 (W)

VAT numbers: DE 227 566 961

Primary location: San Francisco United States